Articles related to "Hiv Vaccine"

A recent U.S. funded study may be showing a promise of a possible HIV vaccine that may reduce the number of newly infected people with the AIDS disease worldwide.

Merck has stopped clinical trials for an HIV vaccine that initially carried so much promise.

Two decades after its discovery, researchers have not found an effective vaccine for the "AIDS virus." While much is known about this agent, HIV's biology remains vexing.

Encouraging results of the world's largest HIV vaccine trial had scientists ready to believe vaccinations to combat the AIDS-causing virus would soon be a reality.

A $20.5 million grant enables expansion of an international program investing the biological factors underlying immune system control of HIV, the virus that causes AIDS.

Most sexually transmitted infections are relatively easy to cure. Untreated infection can lead to more serious complications and the risk of infecting others.

The lives of AIDS patients are hinging on new treatments, but preventing HIV infection is still a challenge. Here is a summary of recent developments.

The Age of Enlightenment promoted reason and scientific knowledge, but sometimes new medical treatments were suggested by influential patients and not physicians.

Rapamycin has researchers believing it can treat pancreatic cancer, prevent childhood epilepsy, improve vaccine effectiveness and expand human life span.